No Data
No Data
No Data
BRIEF-Spero Therapeutics Enters Into Agreement With Healthcare Royalty Partners
Sept 30 (Reuters) - Spero Therapeutics Inc SPRO.O :* SPERO THERAPEUTICS ENTERS INTO A NON-DILUTIVE REVENUE INTEREST FINANCING AGREEMENT WITH HEALTHCARE ROYALTY PARTNERS® FOR UP TO $125 MILLION* SPERO
Spero Therapeutics Inks Revenue Interest Financing Agreement With HealthCare Royalty Partners
Published: 09/30/2021SPROSpero Therapeutics Inc (NASDAQ: SPRO) has entered into a revenue interest financing agreement with HealthCare Royalty Partners for up to $125 million. Spero...Read more: Benz
ADC Therapeutics Announces $325M Financing Agreement With HealthCare Royalty
Published: 08/26/2021ADCTADC Therapeutics SA (NYSE: ADCT) has entered into a royalty purchase agreement with HealthCare Royalty Partners for up to $325 million. ADC Therapeutics...Read more: Benzinga
US stock IPO | WCG Clinical is listed this week! Supported by GIC and private equity fund Leonard Green
There were 9 traditional IPOs this week. Among them, WCG Clinical, supported by private equity fund Leonard Green & Partners, and outdoor cooking industry leader Weber received the most attention.
IPO Forecast | 11 companies IPOs in the US this week, raising a cumulative amount of 3.48 billion US dollars
This week, US stocks will welcome the listing of 11 companies, including 9 IPOs and 2 SPAC listings.
US stock IPO forecast for this week: 7 companies, follow WCGC and WEBR
The number of US stock IPOs this week is much lower than the previous two weeks. Generally, the beginning of the month was relatively depressed, which is normal. Here's an introduction to 7 companies that will go public with IPOs this week. 1. 8/2 (Mon) — REIT company: Rox Financial LP (ROXA) is likely to continue to delay listing like last week. Rox Financial LP (AMEX: ROXA) was founded in 2020, also known as ROX LP, and is headquartered in New York City, New York, USA. It is a newly established Delaware series limited partnership that aims to expand access differentiation
No Data